Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials.
about
Topical tacrolimus for atopic dermatitisTopical tacrolimus for atopic dermatitisDeciphering the complexities of atopic dermatitis: shifting paradigms in treatment approachesThe ABC's of managing patients with severe atopic dermatitisComputational design of treatment strategies for proactive therapy on atopic dermatitis using optimal control theory.What's new in atopic eczema? An analysis of systematic reviews published in 2010-11.Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.Validation of the global resource of eczema trials (GREAT database).Validation of treatment escalation as a definition of atopic eczema flares.Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approachesAtopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology.Maintenance Therapy of Facial Seborrheic Dermatitis with 0.1% Tacrolimus Ointment.Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part I): General Management and Topical Treatment.Prevention of atopic dermatitis.Pathways to managing atopic dermatitis: consensus from the expertsTopical Therapy in Atopic Dermatitis in Children.Awareness of Atopic Dermatitis and Attitudes toward Different Types of Medical Institutions for Its Treatment among Adult Patients and the Parents of Pediatric Patients: A Survey of 500 Participants.Topical therapies for pruritus.Atopic dermatitis and the atopic march: what is new?Topical fluticasone propionate: intervention and maintenance treatment options of atopic dermatitis based on a high therapeutic index.Therapy of severe atopic dermatitis in adults.Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting.Long term treatment concepts and proactive therapy for atopic eczema.How are eczema 'flares' defined? A systematic review and recommendation for future studies.New approaches to the prevention of childhood atopic dermatitis.Atopic dermatitis: an evidence-based treatment update.Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis.Optimizing outcomes for paediatric atopic dermatitis.Extended implementation of educational programs for atopic dermatitis in childhood.Factors contributing to poor treatment outcomes in childhood atopic dermatitis.Hand dermatitis--differential diagnoses, diagnostics, and treatment options.Review of Atopic Dermatitis and Topical Therapies.Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016.Measuring long-term disease control in patients with atopic dermatitis: A validation study of well-controlled weeks.What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials.A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal.Potential preventive effects of proactive therapy on sensitization in moderate to severe childhood atopic dermatitis: A randomized, investigator-blinded, controlled study.Current Understanding in Pathogenesis of Atopic Dermatitis.Barrier function and microbiotic dysbiosis in atopic dermatitisTopical corticosteroid application and the structural and functional integrity of the epidermal barrier.
P2860
Q24186624-974BB942-EE9A-49E1-8DFD-F640335A38C6Q24198110-31C5DB69-6F99-453C-B7F5-E8C45C3EC268Q26852335-49CD21FA-4834-4C90-9538-735F703BB386Q27022610-E888EB33-76E0-43CA-BE92-8018E05F236DQ33694845-E7A2A482-7DFB-426A-A304-66AF8254494CQ34349733-B9A70B83-72D9-4D94-86EF-59C04B737ACAQ35077866-17DA8338-ED3A-4C35-ADDF-0DC5F29AA3A8Q35194730-2F8F705F-51B2-4404-AE37-DBAD87BE5EB5Q35515891-D461BAAA-5255-477F-878E-E7973953DF6BQ35603170-F0F5772C-600B-499F-899B-0C5618D529BCQ36048469-18E07315-F9C3-4CC3-8B8A-8228D0C5C8DCQ36214225-3C63A456-4492-474D-9607-34CDFB131FDDQ36214247-13B6508C-CBA7-427C-B324-1075FCF60F42Q36449701-AC6CFC79-7418-4869-B0B8-9A68DD6C0153Q37258723-56645389-FEA3-4A96-981E-F12D1106AFD4Q37437047-9AD1918F-7BE9-42EC-A89F-508F13210471Q37446817-78CE9B48-5AB6-417C-AE39-BB2C271C6D31Q37902324-7691F078-C8B8-4F40-81C6-48C8F70E0505Q37937455-5A576838-27B0-4199-9C5D-EE88A7A4CB84Q37942962-F0D976C4-296F-41ED-9E96-C8B73BE5E9E8Q38011193-270CFD87-34F9-4C27-B308-608F8D5AD876Q38030564-3AB9174A-230D-4C25-8EAD-C6648BE8AB8DQ38033549-CDCE1BAC-B4E0-44A1-99D5-21BA20777EA2Q38165233-E425E9C2-FCF5-470E-A373-5FCA4BC228B4Q38174084-19A570E6-652F-450F-9DA4-CDBD98059981Q38182048-277A53E8-E0E3-4037-82E5-118E09AB6DEAQ38195864-E5C30907-A8D9-43CB-8E5E-CD5C8106C7DBQ38203613-8D26ADA6-8032-4466-BC16-4FF62F5BBBDCQ38364902-55BCC328-1D8D-4E97-8D6F-6EB970137BCBQ38394059-B0890803-6320-4F59-A21B-936A126D114BQ38682128-7F50B36D-9DF5-48B3-BE76-1F483CC091F5Q38744304-54571FE7-62CA-45CA-87F4-8A2A7C03BDADQ38807878-DBCF3337-2D12-43ED-9D33-88D52AFFCE6AQ38812765-280C68A3-240B-45C3-A8F7-91DEE27DD7BCQ38933737-5DE68EA3-C7CD-4323-9322-DC32532B0859Q40068394-88EB6EFF-67DB-4D16-A603-FA0C07E7EEA7Q40484107-8ECF225B-8D78-483A-9012-A1674316CC7DQ41823296-270DCE09-D056-4D3A-B521-E114BED73A8BQ41904665-1DC040AB-9C59-48E8-963E-03E35761D1D2Q42851212-70618960-9458-4F28-B010-588464752B57
P2860
Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Efficacy and tolerability of p ...... randomized controlled trials.
@ast
Efficacy and tolerability of p ...... randomized controlled trials.
@en
type
label
Efficacy and tolerability of p ...... randomized controlled trials.
@ast
Efficacy and tolerability of p ...... randomized controlled trials.
@en
prefLabel
Efficacy and tolerability of p ...... randomized controlled trials.
@ast
Efficacy and tolerability of p ...... randomized controlled trials.
@en
P2093
P2860
P1476
Efficacy and tolerability of p ...... randomized controlled trials.
@en
P2093
A Svensson
C Apfelbacher
L von Kobyletzki
P2860
P304
P356
10.1111/J.1365-2133.2010.10030.X
P407
P577
2010-11-23T00:00:00Z